SETD4 and prostate carcinoma: According to the TCGA database and two reports (41,42), SETD4 was fused with TMPRSS2 and ERG in prostate cancers, with FTCD in invasive ductal carcinoma, with KIAA1958 in serous ovarian cancer and with B4Galt6 in lung squamous cancer.